Get started
Author

Mikio Okayama

Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus
2020 · Yasushi Kondo, Yuko Kaneko, et al. · Annals of the Rheumatic Diseases · 24
Interleukin-6-producing Intravascular Large B-cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease
2020 · Kohei Shiroshita, Taku Kikuchi, et al. · Internal Medicine · 9
PDF
Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma
2017 · Yutaka Suto, Mariko Sato, et al. · Bioorganic & Medicinal Chemistry Letters · 9
Impact of immunoglobulin G2 subclass level on late‐onset bacterial infection after allogeneic hematopoietic stem cell transplantation
2019 · Rie Yamazaki, Jun Kato, et al. · Transplant Infectious Disease · 7
A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress
2018 · Mikio Okayama, Shotaro Kitabatake, et al. · Biochemical and Biophysical Research Communications · 5
GTN057 , a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c‐MET tyrosine kinase
2023 · Mikio Okayama, Kota Fujimori, et al. · Cancer Medicine · 4
PDF
Efficacy of ondansetron against emesis induced by a multiple-day cisplatin-based chemotherapy regimen for malignant lymphoma
2021 · Takahiro Kamiya, Masatoshi Sakurai, et al. · Hematology · 4
Thromboembolism Early After Glucocorticoid Administration in Patients with Autoimmune Hemolytic Anemia
2023 · Kohei Shiroshita, Mikio Okayama, et al. · Clinical Hematology International · 3
PDF
Successful Treatment of End-stage Renal Disease in a Patient With Chronic Myeloid Leukemia by Kidney Transplantation and Tyrosine Kinase Inhibitors: A Case Report
2020 · Kazunobu Shinoda, Shinya Morita, et al. · Transplantation Proceedings · 3
Dasatinib-Triggered Severe Hypocalcemia in a Patient with Chronic Kidney Disease and Osteoporosis
2023 · Kohei Shiroshita, Mikio Okayama, et al. · Cureus · 2
PDF
[Cellulitis due to Achromobacter xylosoxidans during bortezomib therapy for multiple myeloma].
2016 · Taku Kikuchi, Takehiko Mori, et al. · PubMed · 2
Clinical Images: Epistaxis may be a warning sign of lymphoproliferative disorder during methotrexate treatment for dermatomyositis
2023 · Sho Ishigaki, Nobuhiko Kajio, et al. · ACR Open Rheumatology · 1
PDF
The Impact of Pretransplant Use of Tyrosine Kinase Inhibitors on Allogeneic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia - A Single-institution Retrospective Study -
2023 · Shinya Fujita, Masatoshi Sakurai, et al. · Internal Medicine · 1
PDF
[Systemic varicella-zoster infection during ixazomib-containing multiagent chemotherapy for multiple myeloma].
2020 · Hitomi Nakayama, Jun Kato, et al. · PubMed · 1
A Case of Insulin Autoimmune Syndrome Complicated by IgG4-Related Disease, Both Successfully Treated with Corticosteroids
2026 · Yosuke Oshima, Naohiro Saito, et al. · Internal Medicine
PDF
同種造血幹細胞移植後の遅発性細菌感染に対する免疫グロブリンg2サブクラスレベルの影響【jst・京大機械翻訳】
2019 · Rie Yamazaki, Jun Kato, et al. · Transplant Infectious Disease
Structural modification and anti-myeloma activities of natural product, komaroviquinone
2018 · Mikio Okayama · The Japanese Society of Hematology
A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress (要旨)
2018 · オカヤマ, ミキオ, Okayama, Mikio, et al. · KeiO Associated Repository of Academic Resources (Keio University)
A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress (審査報告)
2018 · オカヤマ, ミキオ, Okayama, Mikio, et al. · KeiO Associated Repository of Academic Resources (Keio University)
A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress (本文)
2018 · オカヤマ, ミキオ, Okayama, Mikio, et al. · KeiO Associated Repository of Academic Resources (Keio University)
A Novel Phthalimide-Derivative, TC11, Induced G2/M Arrest and Apoptosis of High-Risk Myeloma Cells By Interacting with Nucleophosmin1 and α-Tubulin, but Not By Binding to Celeblon
2017 · Misa Nakamura, Daiju Ichikawa, et al. · Blood
Abstract 5121: PEG(E)-TC11, a novel polyethylene glycol-linked phthalimide derivative, inhibited high-risk MM cell growth in vivo and in vitro via cell cycle G2/M arrest in a CRBN-independent manner
2017 · Shuji Aida, Daiju Ichikawa, et al. · Cancer Research
Allogeneic hematopoietic stem cell transplantation following treatment with brentuximab vedotin for refractory Hodgkin lymphoma.
2017 · Yusuke Yamane, Yuya Koda, et al. · PubMed
Pomalidomide for patients with relapsed and refractory multiple myeloma in clinical setting
2017 · Taku Kikuchi, Mori Takehiko, et al. · 臨床血液
Komaroviquinone-Derivatives, Revealed Anti-Tumor Effect on High-Risk Multiple Myeloma Cells In Vitro as Well as In Vivo
2016 · Mariko Sato, Kota Fujimori, et al. · Blood
Works count: 26
Citation count: 75
H-index: 5
I10-index: 1
Year
Topic
Type